Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions

Hippocampus

Volumn 8, Issue 6, 1998, Pages 566-607

  Vizi, E Sylvester ^a   Kiss, Janos P ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Acetylcholine; GABA; Glutamate; Nonsynaptic interactions; Noradrenaline; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; GLUTAMIC ACID; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ARTICLE; BRAIN FUNCTION; CELL COMMUNICATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; LEARNING; MEMORY; NERVE ENDING; NEUROCHEMISTRY; NEUROTRANSMITTER RELEASE; PHARMACOLOGY; PRIORITY JOURNAL; SYNAPSE;

ANIMALS; BRAIN; HIPPOCAMPUS; HUMANS; MODELS, NEUROLOGICAL; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROTRANSMITTER; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0032420026     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W     Document Type: Article

References (384)

1. Abercrombie ED, Keller RW Jr, Zigmond MJ. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 1988;27:897-904.
2. Acsády L, Halasy K, Freund TF. Calretinin is present in non-pyramidal cells of the rat hippocampus-III. Their inputs from the median raphe and medial septal nuclei. Neuroscience 1993-52:829-841.
3. Acsády L, Arabadzisz D, Freund TF. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in rat hippocampus. Neuroscience 1996;73:299-315.
4. Agnati LF, Zoli M, Stromberg I, Fuxe K. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience 1995;69: 711-726.
5. Albuquerque EX, Atkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CTF, Bonfante-Cabracas R, Aracava Y, Eisenberg HM, Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 1997;280:1117-1136.
6. Alkondon M, Pereira EFR, Barbosa CTF, Albuquerque EX. Neuronal nicotinic acetylcholine receptor activatiom modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther 1997;283:1396-1411.
7. + channel blockers on the alpha 2-adrenoceptor-coupled regulation of electrically evoked noradrenaline release in hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1993;347:14-20.
8. 3H]-noradrenaline release in rabbit hippocampus and human neocortex. Br J Pharmacol 1995;116: 1769-1774.
9. Alonso A, Köhler C. Evidence for separate projections of hippocampal pyramidal and non-pyramidal neurons to different parts of the septum in the rat brain. Neurosci Lett 1982;31:203-214.
10. Amaral DG, Witter MP. The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience 1989;31:571-591.
11. Amaral DG, Witter MP. Hippocampal formation. In: Paxinos G, ed. The rat nervous system. New York: Academic Press, 1995;443-494.
12. Anderson JL. Serotonin receptor changes after chronic antidepressant treatments: ligand binding, dectrophysiological, and behavioral studies. Life Sci 1983;32:1791-1801.
13. 2+ uptake in diazepam withdrawal: inhibition by baclofen. Pharmacol Biochem Behav 1992;41:695-699.
14. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J Neurochem 1988;51:292-299.
15. Araujo DM, Lapchak PA, Meaney MJ, Collier B, Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites, J Neurosci 1990;10:3069-3078.
16. Arqueros L, Naquira D, Zunino E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem Pharmacol 1978;27:2667-2674.
17. Asztely F, Erdemli G, Kullmann DM. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron 1997;18:281-293.
18. Ayyagari V, Harrell LE, Parsons DS. Interaction of neurotransmitter systems in the hippocampus: a study of some behavioral effects of hippocampal sympathetic ingrowth. J Neurosci 1991;11:2848-2854.
19. 3H]glutamate in rat hippocampal slices. J Neurochem 1983;40:280-284.
20. Bach-y-Rita P. Neurotransmission in the brain by diffusion through the extracellular fluid a review. Neuroreport 1993;4:343-350.
21. Bach-y-Rita P. Aiello GL. Nerve length and volume in synaptic vs diffusion neurotransmission: a model. Neuroreport 1996;7:1502-1504.
22. 3H-serotonin release from hippocampal synaptosomes. Eur J Pharmacol 1980;68:11-16.
23. Barbour B, Hausser M. Intersynaptic diffusion of neurotransmitter. Trends Neurosci 1997;20:377-384.
24. 3H]-L-glutamate release from rat hippocampal synaptosomes. Br J Pharmacol 1994;113:339-341.
25. Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 1993;11:771-787.
26. Behrends JC, ten Bruggencate G. Cholinergic modulation of synaptic inhibition in the guinea pig hippocampus in vitro: excitation of GABAergic intemeurons and inhibition of GABA-release. J Neurophysiol 1993;69:626-629.
27. Ben-Ari Y, Represa A. Brief seizure episodes induce long-term potentiation and mossy fibre sprouting in the hippocampus. Trends Neurosci 1990;13:312-318.
28. 3H]S-HT release after noradrenergic denervation with DSF4. Eur J Pharmacol 1985;119:131-133.
29. Benveniste H, Hürtemeier PC. Microdialyas - theory and application. Prog Neurobiol 1990;35:195-215.
30. Bergles DE, DOZE VA, Madison DV, Smith SJ. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J Neurosci 1996;16:572-585.
31. Bijak M, Misgeld U. Adrenergic modulation of hilar neuron activity and granule cell inhibition in the guinea-pig hippocampal slice. Neuroscience 1995;67:541-550.
32. Bijak M, Misgeld U. Effects of serotonin through serotonin1A and serotonin4 receptors on inhibition in the guinea-pig dentate gyrus in vitro. Neuroscience 1997;78:1017-1026.
33. Birch PJ, Fillenz M. Stimulation of noradrenaline synthesis by the calcium ionophore A23187 and its modulation by presynaptic receptors. Neurosci Lett 1985;62:187-192.
34. 3H]noradrenaline release from guinea pig ileal myenteric plexus and noradrenergic terminals is modulated by different presynaptic alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther 1993;267:1054-1060.
35. Blier P, Bouchard C. Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain. Br J Pharmacol 1993;108:13-22.
36. Blier P, Bouchard C. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 1994;113:485-495.
37. Blier P, Lista A, De Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther 1993a;265:16-23.
38. 3H]5-HT release in the guinea pig hypothalamus are not autoreceptors. Synapse 1993b;15:143-148.
39. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-39.
40. Bolanos F, Fillion G. Minaprine antagonises the serotonergic inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on acetylcholine release. Eur J Pharmacol 1989;168:87-92.
41. Bolanos-Jimenez F, Manhaes de Castro R, Fillion G. Effect of chronic antidepressant treatment on 5-HT1B presynaptic heteroreceptors inhibiting acetylcholine release. Neuropharmacology 1994;33:77-81.
42. Bolanos-Jimenez F, Manhaes de Castro RM, Seguin L, Cloez-Tayarani I, Monneret V, Drieu K, Fillion G. Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur J Pharmacol 1995;294:531-540.
43. Bonanno G, Raiteri M. Carriers for GABA and noradrenaline uptake coexist on the same nerve terminal in rat hippocampus. Eur J Pharmacol 1987a;136:303-310.
44. 3H]acetylcholine release sensitive to inhibitors of gamma-aminobutyric acid uptake. J Neurochem 1987b;48:1454-1458.
45. Bonanno G, Raiteri M. Presence of a gamma-aminobutyric acid (GABA) uptake system on cholinergic terminals of rat hippocampus: evidence for neuronal coexistence of acetylcholine and GABA? J Pharmacol Exp Ther 1987c;240:294-297.
46. A receptors are present on noradrenergic nerve terminals in selective areas of the rat brain. Synapse 1987d;1:254-257.
47. Bonanno G, Raiteri M. A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals. J Neural Transm 1987e;69:59-70.
48. Bonanno G, Raiteri M. Functional evidence for multiple gamma-aminobutyric atidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 1992;262:114-118.
49. B-type in human cerebral cortex. Br J Pharmacol 1989a;96:341-346.
50. 3H]norepinephrine in rat hippocampus. J Neurochem 1989b;52:1854-1858.
51. Bonanno G, Pittaluga A, Fedele E, Fontana G, Raiteri M. Glutamic acid and gamma-aminobutyric acid modulate each other's release through heterocarriers sited on the axon terminals of rat brain. J Neurochem 1993;61:222-230.
52. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 1989;35:469-476.
53. Burke SP, Nadler JV. Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J Neurochem 1988;51:1541-1551.
54. Bylund DB. Subtypes of alpha 1- and alpha 2-adrenergjc receptors. FASEB J 1992;6:832-839.
55. Bylund DB, Ray-Prenger C, Murphy TJ. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 1988;245: 600-607.
56. Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lefkowitz RJ, Lomasney JW. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 1992;42:1-5.
57. Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 1998;32:117-131.
58. Castillo PE, Malenka RC, Nicoll RA. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 1997;388: 182-186.
59. Cerrito F, Raiteri M. Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol 1979;57:427-430.
60. Chaki S, Usuki-Ito C, Muramatsu M, Otomo S. Differentiation of the active site of minaprine from that of phencyclidine in rat hippocampus. Res Commun Chem Pathol Pharmacol 1990;69:85-98.
61. Chesselet MF. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 1984;12:347-375.
62. Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL, Henley JM. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 1996;379:78-81.
63. 3H]-dopamine release. Br J Pharmacol 1996;117:595-606.
64. Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Omstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. A hippocampal Glu25 kainate receptor regulating inhibitory synaptic transmission. Nature 1997;389:599-603.
65. Clements JD, Lester RA, Tong G, Jahr CE, Wesfbrook GL. The time course of glutamate in the synaptic cleft. Science 1992;258:1498-1501.
66. 3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents. Fundam Clin Pharmacol 1992;6:333-341.
67. 3H]-noradrenaline release in rat hippocampal synaptosomes. Br J Pharmacol 1996;118:901-904.
68. Conrad L, Leonard CM, Pfaff DW. Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study. J Comp Neurol 1974;156:179-206.
69. 4 receptor stimulation facilitates acetyicholine release in rat frontal cortex. Neuroreport 1994a;5:1230-1232.
70. 3 receptors. J Neurochem 1994b;62:2254-2261.
71. Cotman CW, Flatman JA, Ganong AH, Perkins MN. Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus. J Physiol (Lond) 1986;348:403-415.
72. Cowen MS, Beart PM. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices. Br J Pharmacol 1998;123:473-480.
73. 3H] gamma-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur J Pharmacol 1997;323:167-172.
74. Curet O, De Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res 1988a;475:35-46.
75. Curet O, De Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine. Brain Res 1988b;475: 47-57.
76. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamine cell bodies in brain stem neurons. Acta Physiol Scand 1964;62, suppl. 232:1-55.
77. B autoreceptors regulate the induction of LTP. Nature 1991;349:609-611.
78. De Biasi S, Vitellaro-Zuccarello L, Brecha NC. Immunoreactivity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. Alight and dectron-microscopic immunolocalization. Neuroscience 1998;83:815-828.
79. DeBoer T, Ruigt GSF, Berendsen HHG. The Alpha(2)-sdective adrenoceptor antagonist ORG-3770 (Mirtazapine, Remeron(R)) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol Clin Exp 1995;10:S107-S118.
80. DeBoer TH, Nefkens F, van Helvoirt A, van Delft AM. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J Pharmacol Exp Ther 1996;277:852-860.
81. De Keyser J, Ebinger G, Vauquelin G. Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci Lett 1989;104:281-285.
82. 3H]norepinephrine release in rat hippocampal slices. Neuropharmacology 1995;34:141-147.
83. De Sarno P, Giacobini E. Modulation of acetylcholine release by nicotinic receptors in the rat brain. J Neurosci Res 1989;22:194-200.
84. Descarries L, Saucier G. Disappearence of the locus coeruleus in the rat after intraventricular 6-hydroxydopamine. Brain Res 1972;37:310-316.
85. Descarries L, Watkins KC, Lapierre Y. Noradrenergic axon terminals in the cerebral cortex of rat. III. Topometric ultrastructural analysis. Brain Res 1977;133:197-222.
86. Dineley-Miller K, Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res Mol Brain Res 1992;16:339-344.
87. 2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br J Pharmacol 1992;107:240-245.
88. 2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 1994;33:411-421.
89. Doolette DJ. Mechanism of adenosine accumulation in the hippocampal slice during energy deprivation. Neurochem Int 1997;30:211-223.
90. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 1991;256:727-733.
91. During MJ, Ryder KM, Spencer DD. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 1995;376:174-177.
92. Elenkov IJ, Vizi ES. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 1991;30:1319-1324.
93. Erb C, Klein J, Koppen A, Loffelholz K, Jeltsch H, Cassel JC. Modulation of hippocampal acetylcholine release after fimbria-fornix lesions and septal transplantation in rats. Neurosci Lett 1997;231:5-8.
94. Fan SG, Lee CM, Assaf SY, Iversen LL. Endogenous GABA release from slices of rat cerebral cortex and hippocampus in vitro. Brain Res 1982;235:265-270.
95. Fassio A, Bonanno G, Fontana G, Usai C, Marchi M, Raiteri M. Role of external and internal calcium on heterocarrier-mediated transmitter release. J Neurochem 1996;66:1468-1474.
96. Feuerstein TJ, Hertting G. Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol 1986;333: 191-197.
97. Feuerstein TJ, Hertting G, Jackisch R. Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol 1985;329:216-221.
98. Feuerstein TJ, Lupp A, Hertting G. The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit role of 5-HT biophase concentration. Neuropharmacology 1987;26:1071-1080.
99. Feuerstein TJ, Gleichauf O, Landwehrmeyer GB. Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons. Naunyn Schmiedebergs Arch Pharmacol 1996;354:618-626.
100. Forsythe ID, Clements JD. Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones. J Physiol (Lond) 1990;429:1-16.
101. Frankhuyzen AL, Mulder AH. Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus. Eur J Pharmacol 1980;63:179-182.
102. 3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 1982;81:97-106.
103. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 1998;18:1187-1195.
104. Freund TF. GABAergic septal and serotonergic median raphe afferents preferentially innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Res Suppl 1992;7:79-91.
105. Freund TF, Antal M. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature 1988;336:170-173.
106. Freund TF, Buzsáki G. Interneurons of the hippocampus. Hippocampus 1996;6:347-470.
107. Freund TF, Gulyas AI, Acsády L, Gorcs T, Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci U S A 1990;87:8501-8505.
108. Frotscher M, Leranth C. Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: a combined light and electron microscopic study. J Comp Neurol 1985;239:237-246.
109. Frotscher M, Leranth C. Catecholaminergic innervation of pyramidal and GABAergic non-pyramidal neurons in the rat hippocampus. Double label immunostaining with antibodies against tyrosine hydroxylase and glutamate decarboxylase. Histochemistry 1988;88:313-319.
110. Frotscher M, Schlander M, Leranth C. Cholinergic neurons in the hippocampus. A combined light- and electron-microscopic immunocytochemical study in the rat. Cell Tissue Res 1986;246:293-301.
111. Fujii T, Yoshizawa M, Nakai K, Fujimoto K, Suzuki T, Kawashima K. Demonstration of the facilitatory role of 8-OH-DPAT on Cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res 1997;761:244-249.
112. Fung SC, Fillenz M. The role of presynaptic GABA and benzodiazepine receptors in the control of noradrenaline release in rat hippocampus. Neurosci Lett 1983;42:61-66.
113. Fuxe K, Agnati LF, eds. Volume transmission in the brain. New York: Raven Press, 1991.
114. Gally JA, Montague PR, Reeke GN Jr, Edelman GM. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci U S A 1990;87:3547-3551.
115. Galzin AM, Langer SZ. Modulation of 5-HT release by presynaptic inhibitory and facilitatory 5-HT receptors in brain slices. Adv Biosci 1991;82:59-62.
116. 3H]hydroxytryptamine in slices of the human neocortex. J Neurochem 1992;59:1293-1301.
117. Gannon RL, Terrian DM. Presynaptic modulation of glutamate and dynorphin release by excitatory amino acids in the guinea-pig hippocampus. Neuroscience 1991;41:401-410.
118. Gannon RL, Baty LT, Terrian DM. L(+)-2-amino-4-phosphonobutyrate inhibits the release of both glutamate and dynorphin from guinea pig but not rat hippocampal mossy fiber synaptosomes. Brain Res 1989;495:151-155.
119. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 1985;57:683-706.
120. Gegelashvili G, Schousboe A. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 1998;45:233-238.
121. Getting SJ, Segieth J, Ahmad S, Biggs CS, Whitton PS. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res 1996;717:196-199.
122. Gonzales RA, Brown LM, Jones TW, Trent RD, Westbrook SL, Leslie SW. N-methyl-D-aspartate mediated responses decrease with age in Fischer 344 rat brain. Neurobiol Aging 1991;12:219-225.
123. Gonzalez-Alvear GM, Werling LL. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res 1995;673: 61-69.
124. 2 receptors. Eur J Pharmacol 1988;154:285-291.
125. German LK, Pang K, Frick KM, Givens B, Olton DS. Acetylcholine release in the hippocampus effects of cholinergic and GABAergic compounds in the medial septal area. Neurosci Lett 1994;166:199-202.
126. Gothert M, Weinheimer G. Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 1979;310:93-96.
127. Gramsbergen JB, Schmidt W, Turski WA, Schwarcz R. Age-related changes in kynurenic acid production in rat brain. Brain Res 1992;588:1-5.
128. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996;383:713-716.
129. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995;57:737-769.
130. Gulyas AI, Göres TJ, Freund TF. Innervation of different peptide-containing neurons in the hippocampus by GAB Aergic septal afferents. Neuroscience 1990;37:31-44.
131. Gulyas AI, Hajos N, Freund TF. Interneurons containing calretinin are specialized to control other intemeurons in the rat hippocampus. J Neurosci 1996;16:3397-3411.
132. 3H]acetylcholine release from slices of rat hippocampus, striatum and cortex. Brain Res 1977;123:311-322.
133. Hájos N, Papp EC, Acsády L, Levey AI, Freund TF. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 1998;82:355-376.
134. 1 receptors. Eur J Pharmacol 1996;314:285-291.
135. Halasy K, Somogyi P. Distribution of GABAergic synapses and their targets in the dentate gyrus of rat: a quantitative immunoelectron microscopic analysis. J Hirnforsch 1993;34:299-308.
136. Halasy K, Miettinen R, Szabat E, Freund TF. GABAergic intemeurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus. Eur.J. Neurosci 1992;4:144-153
137. Hancock AA, Buckner SA, Giardina WJ, Brune ME, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ. Preclinical pharmacological actions of (+/-)-(1′R*,3R*)-3-phenyl-1-[T(1′,2′,3′, 4′-tetrahydro-5′,6′-methylene-dioxy-1′-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. J Pharmacol Exp Ther 1995;272:1160-1169.
138. 3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A 1B, and 1C subtypes. J Neurochem 1991-56:221-227.
139. 3H]GABA from hippocampal neurons in primary culture. Brain Res 1989;482: 23-33.
140. Hasko G, Elenkov IJ, Vizi ES. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol Lett 1995;47:133-137.
141. Hawkins RD, Zhuo M, Arancio O. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation. J Neurobiol 1994;25:652-665.
142. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 1987;23:1-38.
143. Herrera DG, Maysinger D, Goiny M. Induction of c-FOS immunoreactivity in the hippocampus following potassium stimulation. Neuroscience 1993;52:237-244.
144. Hille B. G protein-coupled mechanisms and nervous signaling. Neuron 1992;9:187-195.
145. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur J Pharmacol 1991;209:249-252.
146. Hortnagl H, Hellweg R. Insights into the role of the cholinergic component of the septohippocampal pathway: what have we learned from experimental lesion studies? Brain Res Bull 1997;43:245-255.
147. Hortnagl H, Berger ML, Reither H, Hornykiewicz O. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: effect on glutamatergic systems. Naunyn Schmiedebergs Arch Pharmacol 1991;344:213-219.
148. Illes P. Mechanisms of receptor-mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurones. Neuroscience 1986;17:909-928.
149. Imperato A, Dazzi L, Obinu MC, Gessa GL, Biggio G. Inhibition of hippocampal acetylcholine release by benzodiazepines: antagonism by flumazenil. Eur J Pharmacol 1993;238:135-137.
150. Imperato A, Dazzi L, Obinu MC, Gessa GL, Biggio G. The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus. Brain Res 1994;647:167-171.
151. Isaacson JS, Solis JM, Nicoll RA. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 1993;10:165-175.
152. 1A receptor enhances acetylcholine release in conscious rats. J Neurochem 1994;62:1804-1808.
153. Jackisch R, Werle E, Hertting G. Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro. Neuropharmacology 1984;23:1363-1371.
154. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system Physiol Rev 1992;72:165-229.
155. Janaky R, Saransaari P, Oja SS. Release of GABA from rat hippocampal slices: involvement of quisqualate/N-methyl-D-aspartate-gated ionophores and extracellular magnesium. Neuroscience 1993;53:779-785.
156. 3H]GABA release from rat hippocampal slices: involvement of metabotropic glutamate receptors in the quisqualate-evoked release. Neurochem Res 1994;19:729-734.
157. Jones S, Yakel JL. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol (Lond) 1997;504:603-610.
158. 3H]norepinephrine release. J Pharmacol Exp Ther 1987;240:492-497.
159. Kalén P, Strecker RE, Rosengren E, Björklund A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J Neurochem 1988;51:1422-1435.
160. Keith RA, Mangano TJ, Meiners BA, Stumpo RJ, Klika AB, Patel J, Salama AI. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release. Eur J Pharmacol 1989;166:393-400.
161. B receptors. J Neurophysiol 1995;74: 2126-2137.
162. Kirpekar SM, Puig M. Effect of flow stop on noradrenaline release from normal spleen and spleens treated with cocaine, phentolamine or phenoxybenzamine. Br J Pharmacol 1971;43:359-369.
163. Kiss JP, Zsilla G, Mike A, Zelles T, Toth E, Lajtha A, Vizi ES. Subtype-specificity of the presynaptic alpha 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res 1995;674: 238-244.
164. Kiss JP, Sershen H, Lajtha A, Vizi ES. Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neurosci Lett 1996;215:115-118.
165. Kiss JP, Windisch K, Balla A Sershen H, Lajtha A. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res Bull 1997;43:257-262.
166. Kiss JP, Vizi ES, Westerink BHC. Effect of neostigmine on the hippocampal noradrenaline release: role of cholinergic receptors. Neuroreport 1999;10:(in press).
167. Klein WL, Sullivan J, Skorupa A, Aguilar JS. Plasticity of neuronal receptors. FASEB J 1989;3:2132-2140.
168. Knoll J, Vizi ES. Effect of frequency of stimulation on the inhibition by noradrenaline on the acetylcholine output from parasympathetic nerve terminals. Br J Pharmacol 1971;42:263-272.
169. Kuffler SW, Yoshikami D. The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol (Lond) 1975;251:465-482.
170. Kulak JM, Nguyen TA, Olivera BM, McIntosh JM. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 1997;17:5263-5270.
171. Kullmann DM, Asztely F. Extrasynaptic glutamate spillover in thhe hippocampus: evidence and implications. Trends Neurosci 1998;21:8-14.
172. Kullmann DM, Erdemli G, Asztely F. LTP of AMPA and NMDA receptor-mediated signals: evidence for presynaptic expression and extrasynaptic glutamate spill-over. Neuron 1996;17:461-474.
173. Lalies M, Middlemiss DN, Ransom R. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801. Neurosci Lett 1988;91:339-342.
174. B receptor-mediated responses by tetrahydroaminoacridine in area CA3 of the rat hippocampus. J Neurophysiol 1993;69:630-635.
175. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1980;32:337-362.
176. Langer SZ. 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Phamacol Sci 1997;18:95-99.
177. Langer SZ, Adler E, Enero MA, Stefano JFE. The role of alpha receptor in regulating noradrenaline overflow by nerve stimultion. Proc Int Union Physiol Sci 1971;9:335.
178. Lanier SM, Downing S, Duzic E, Homcy CJ. Isolation of rat genomic clones encoding subtypes of the alpha 2-adrenergic receptor. Identification of a unique receptor subtype. J Biol Chem 1991;266:10470-10478.
179. 3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices. Brain Res 1989a;496:285-294.
180. 3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem 1989b;52:483-491.
181. 3H]acetylcholine from rat striatal slices. Brain Res 1982;252:77-89.
182. 3H]5-HT from rat hippocampal slices. Neuropharmacology 1996;35:1769-1777.
183. Leranth C, Frotscher M. Cholinergic innervation of hippocampal GAD-and somatostatin-immunoreactive commissural neurons. J Comp Neurol 1987;261:33-47.
184. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetykholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991;11:3218-3226.
185. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 1995;15: 4077-4092.
186. Levi G, Raiteri M. Carrier-mediated release of neurotransmitters. Trends Neurosci 1993;16:415-419.
187. Levin ED, Torry D, Christopher NC, Yu X, Einstein G, Schwartz-Bloom RD. Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? Brain Res Bull 1997;43:295-304.
188. Leysen J. Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 1984;23:247-254.
189. 1D in the rabbit and guinea-pig brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1991;343:353-364.
190. Lindmar R, Löffelholz K, Muscholl E. A muscarinic mechanism inhibiting the release of noradrenaline from pripheral adrenergic nerve fibers by nicotinic agents. Br J Pharmacol 1968;32:280-294.
191. Liu H, Wang H, Sheng M, Jan LY, Jan YN, Basbaum AI. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A 1994;91:8383-8387.
192. 3H]norepinephrine release. I. The role of glutamate. J Pharmacol Exp Ther 1995;275:7-13.
193. Lopes da Silva FH, Witter MP, Boeijinga PH, Lohman AH. Anatomic organization and physiology of the limbic cortex. Physiol Rev 1990;70:453-511.
194. Loy R, Koziell DA, Lindsey JD, Moore RY. Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 1980;189:699-710.
195. Löffelholz K, Muscholl E. A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Arch Exp Path Pharmacol 1969;265:1-15.
196. 14C]glutamate from dentate but not from CA1/CA3 slices of rat hippocampus. Neuropharmacology 1986;25:493-498.
197. MacDonald E, Kobilka BK, Scheinin M. Gene targeting - homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 1997; 18:211-219.
198. 2+ concentration by presynaptic glutamate receptors in hippocampus. Br J Pharmacol 1994;113:1439-1447.
199. Malva JO, Ambrosio AF, Cunha RA, Ribeiro JA, Carvalho AP, Carvalho CM. A functionally active presynaptic high-affinity kainate receptor in the rat hippocampal CA3 subregion. Neurosci Lett 1995;185: 83-86.
200. Malva JO, Carvalho AP, Carvalho CM. Domoic acid induces the release of glutamate in the rat hippocampal CA3 subregion. Neuroreport 1996;7:1330-1334.
201. 2+ channels, Neurochem Int 1998a;32:7-16.
202. Malva JO, Carvalho AP, Carvalho CM. Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release Neurochem Int 1998b;32:1-6.
203. Mangano TJ, Patel J, Salama AI, Keith RA. Glycine-evoked neurotransmitter release from rat hippocampal brain slices: evidence for the involvement of glutaminergic transmission. J Pharmacol Exp Ther 1990;252:574-580.
204. Manzoni OJ, Manabe T, Nicoll RA. Release of adenosine by activation of NMDA receptors in the hippocampus. Science 1994;265:2098-2101.
205. Marchi M, Raiteri M. Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther 1989;248:1255-1260.
206. Marchi M, Paudice P, Raiteri M. Autoregulation of acetylcholine release in isolated hippocampal nerve endings. Eur J Pharmacol 1981;73: 75-79.
207. 3H]serotonin release in different rat brain areas. Eur J Pharmacol 1986;129:353-357.
208. Marchi M, Bocchieri P, Garbarino L, Raiteri M. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett 1989;96:229-234.
209. 3 receptors in the control of 5-HT release in rat hippocampus in vivo. Br J Pharmacol 1992;106:139-142.
210. Matsumoto M, Yoshioka M, Togashi H, Tochihara M, Ikeda T, Saito H. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis. J Pharmacol Exp Ther 1995;272:1044-1051.
211. Matsuoka Y, Kitamura Y, Fukunaga R, Shimohama S, Nabeshima T, Tooyama I, Kimura H, Taniguchi T. In vivo hypoxia-induced neuronal damage in dentate gyrus of rat hippocampus: changes in NMDA receptors and the effect of MK-801. Neurochem Int 1997;30:533-542.
212. 1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol 1986;129:333-337.
213. Maura G, Gemmignani A, Raiteri M. Noradrenaline inhibits central serotonin release through alpha 2-adrenoceptors located on serotonergic nerve terminals. Naunyn Schmiedebergs Arch Pharmacol 1982; 320:272-274.
214. 1 receptor. Naunyn Schmiedebergs Arch Pharmacol 1986;334: 323-326.
215. Maura G, Pittaluga A, Ulivi M, Raiteri M. Enhancement of endogenous GABA release from rat synaptosomal preparations is mediated by alpha 2-adrenoceptors pharmacologically different from alpha 2-autoreceptors. Eur J Pharmacol 1988;157:23-29.
216. Maura G, Fedele E, Raiteri M. Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine. Eur J Pharmacol 1989;165:173-179.
217. 1D autoreceptors in human cerebral cortex. J Neurochem 1993;60:1179-1182.
218. McBain CJ, Traynelis SF, Dingledine R. Regional variation of extracellular space in the hippocampus. Science 1990;249:674-677.
219. McKinney M, Miller JH, Aagaard PJ. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J Pharmacol Exp Ther 1993;264:74-78.
220. Middlemiss DN. Multiple 5-hydroxytryptamine receptors in the central nervous system of the rat. In: De Belleroche J, ed. Presynaptic receptors: mechanisms and functions. Chichester Ellis Horwood. 1982;46
221. Milner TA, Bacon CE. Ultrastructural localization of tyrosine hydroxylase-like immunoreactivity in the rat hippocampal formation. J Comp Neurol 1989a;281:479-495.
222. Milner TA, Bacon CE. GABAergic neurons in the rat hippocampal formation: ultrastructure and synaptic relationships with catecholaminergic terminals. J Neurosci 1989b;9:3410-3427.
223. Milusheva E, Baranyi M, Zelles T, Mike A, Via ES. Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions. Eur J Neurosci 1994;6:187-192.
224. 14C]GABA in hippocampus slices: the role of sodium channels and cAMP. Brain Res 1989;490:205-211.
225. Mitchell SN. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology 1993;32: 937-949.
226. Mody I, Leung P, Miller JJ. Role of norepinephrine in seizurelike activity of hippocampal pyramidal cells maintained in vitro: alteration by 6-hydroxydopamine lesions of norepinephrine-containing systems. Can J Physiol Pharmacol 1983;61:841-846.
227. Mongeau R, Blier P, De Montigny C. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1993;347:266-272.
228. 3H]noradrenaline in rat brain limbic structures. Eur J Pharmacol 1994a;256:269-279.
229. Mongeau R, De Montigny C, Blier P. Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 1994b;10: 41-51.
230. Mongeau R, Blier P, De Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 1997;23:145-195.
231. 3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedebergs Arch Pharmacol 1992;346:32-39.
232. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 1995;92:3774-3778.
233. 3H]-noradrenaline release in rat hippocampal slices. Br J Pharmacol 1996;119:65-72.
234. Moor E, DeBoer P, Auth F, Westerink BH. Characterisation of muscarinic autoreceptors in the septo-hippocampal system of the rat: a microdialysis study. Eur J Pharmacol 1995;294:155-161.
235. Moor E, Auth F, DeBoer P, Westerink BH. Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: a microdialysis study. J Neurochem 1996;67:310-316.
236. Morales M, Battenberg E, de Lecea L, Bloom FE. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res 1996;731:199-202.
237. Moroni F, Russi P, Carla V, Lombardi G. Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neurosci Lett 1988;94:145-150.
238. Morris ME, Leblond J, Agopyan N, Kmjevic K. Temperature dependence of extracellular ionic changes evoked by anoxia in hippocampal slices. J Neurophysiol 1991;65:157-167.
239. Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Aihara H. Serotonin-2 receptor-mediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat. Neuropharmacology 1988;27:603-609.
240. Murugaiah KD, O'Donnell JM. Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1995;351:483-490.
241. 3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. Neurochem Int 1997;31:113-124.
242. Nakahiro M, Fujita N, Fukuchi I, Saito K, Nishimura T, Yoshida H. Pantoyl-gamma-aminobutyric acid facilitates cholinergjc function in the central nervous system. J Pharmacol Exp Ther 1985;232:501-506.
243. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci 1990;11:462-468.
244. Nilsson OG, Leanza G, Bjorklund A. Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis. Brain Res 1992;584:132-140.
245. Nordstrom O, Bartfai T. Muscarinic autoreceptor regulates acetylcholine release in rat hippocampus: in vitro evidence. Acta Physiol Scand 1980;108:347-353.
246. Ohue T, Koshimura K, Akiyama Y, Ito A, Kido T, Takagi Y, Miwa S. Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection. Brain Res 1992;572:340-344.
247. Okamoto N, Hori S, Akazawa C, Hayashi Y, Shigemoto R, Mizuno N, Nakanishi S. Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J Biol Chem 1994;269:1231-1236.
248. Oleskevich S, Descarries L, Lacaille JC. Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J Neurosci 1989;9:3803-3815.
249. Oleskevich S, Descarries L, Watkins KC, Seguela P, Daszuta A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience 1991;42:777-791.
250. Olney JW. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721.
251. B receptors by spontaneously released transmitter. J Neurophysiol 1992;67:227-235.
252. 3H]noradrenaline release in rat brain cortical and hippocampel synaptosomes. Neurosci Lett 1996;216:187-190.
253. Patneau DK, Mayer ML. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 1990;10:2385-2399.
254. Paton WDM, Vizi ES. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig longitudinal muscle strip. Br J Pharmacol 1969;35:10-28.
255. Pei Q, Zetterstrom T, Fillenz M. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 1989;28:1061-1066.
256. B) receptor subtype. Brain Res 1993;604:325-330.
257. Piguet P, Galvan M. Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. J Physiol (Lond) 1994;481:629-639.
258. Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995;34:1-26.
259. Pinder RM, Wieringa JH. Third-generation antidepressants. Med Res Rev 1993;13:259-325.
260. Pitler TA, Alger BE. Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. J Physiol (Lond) 1992;450:127-142.
261. Pittaluga A, Raiteri M. GABAergic nerve terminals in rat hippocampus possess alpha 2-adrenoceptors regulating GABArelease. Neurosci Lett 1987a;76:363-367.
262. Pittaluga A, Raiteri M. Choline increases endogenous GABA release in rat hippocampus by a mechanism sensitive to hemicholinium-3. Naunyn Schmiedebergs Arch Pharmacol 1987b;336:327-331.
263. Pittaluga A, Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol 1990;191:231-234.
264. Pittaluga A, Raiteri M. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation. J Pharmacol Exp Ther 1992a;263:327-333.
265. Pittaluga A, Raiteri M. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther 1992b;260:232-237.
266. B type. Eur J Pharmacol 1987;144: 45-52.
267. Pittaluga A, Fedele E, Risiglione C, Raiteri M. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol 1993;231: 129-134.
268. Pittaluga A, Pattarini R, Raiteri M. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. Eur J Pharmacol 1995;272:203-209.
269. Pittaluga A, Bonfanti A, Raiteri M. Differential deserialization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedebergs Arch Pharmacol 1997;356:29-38.
270. 3H]acetycholine release from rat hippocampal slices. J Pharmacol Exp Ther 1988;244:213-217.
271. Poli A, Contestabile A, Migani P, Rossi L, Rondelli C, Virgili M, Bissoli R, Barnabei O. Kainic acid differentially affects the synaptosomal release of endogenous and exogenous amino acidic neurotransmitters. J Neurochem 1985;45:1677-1686.
272. Polischuk TM, Andrew RD. Real-time imaging of intrinsic optical signals during early excitotoxicity evoked by domoic acid in the rat hippocampal slice. Can J Physiol Pharmacol 1996;74:712-722.
273. Poncer JC, Shinozaki H, Miles R. Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. J Physiol (Lond) 1995;485:121-134.
274. Potter PE, Nitta S. Alterations in modulation of acetylcholine release following lesion of hippocampal cholinergic neurons with the neurotoxin AF64A. Neuropharmacology 1993;32:519-526.
275. Potter PE, Thorne B, Gaughan C. Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion. Brain Res Bull 1997;42:153-160.
276. Pullan LM, Britt M, Chapdelaine MJ, Keith RA, LaMonte D, Mangano TJ, Patel J, Powel RJ, Stumpo RJ, Warwick PJ. Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-D-aspartate receptor complex. J Neurochem 1990;55:1346-1351.
277. 2)-muscarinic receptor antagonist in aged memory-impaired. J Neurosci 1995;15:1455-1462.
278. Raiteri M, Leardi R, Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther 1984;228:209-214.
279. Raiteri M, Marchi M, Maura G, Bonanno G. Presynaptic regulation of acetylcholine release in the CNS. Cell Biol Int Rep 1989;13:1109-1118.
280. 3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus. Eur J Pharmacol 1990a;184:239-250.
281. Raiteri M, Marchi M, Paudice P, Pittaluga A. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. J Pharmacol Exp Ther 1990b;254:496-501.
282. Raiteri M, Garrone B, Pittaluga A. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. J Pharmacol Exp Ther 1992;260:238-242.
283. 3H]norepinephrine release is modulated by glycine. Eur J Pharmacol 1988;156: 149-155.
284. Rao TS, Correa LD, Lloyd GK. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors. Neuropharmacology 1997;36:39-50.
285. 2 antagonists. Brain Res 1986;385:395-400.
286. Reece LJ, Schwartzkroin PA. Effects of cholinergic agonists on two non-pyramidal cell types in rat hippocampal slices. Brain Res 1991;566:115-126.
287. Ribak CE, Seress L, Peterson GM, Seroogy KB, Fallon JH, Schmued LC. AGABAergic inhibitory component within the hippocampal commissural pathway. J Neurosci 1986;6:3492-3498.
288. 3 receptors. Br J Pharmacol 1990;99:753-761.
289. Riveros N, Fiedler J, Lagos N, Munoz C, Orrego F. Glutamate in rat brain cortex synaptic vesicles: influence of the vesicle isolation procedure. Brain Res 1986;386:405-408.
290. Rodriguez-Moreno A, Herreras O, Lerma J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 1997;19:893-901.
291. Rouse ST, Levey AI. Muscarinic acetylcholine receptor immunoreactivity after hippocampal commissural/associational pathway lesions: evidence for multiple presynaptic receptor subtypes. J Comp Neurol 1997;380:382-394.
292. 1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur J Pharmacol 1993;239:195-202.
293. Rowley HL, Martin KF, Marsden CA. Decreased GABArelease following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo. Neuroscience 1995;68:415-422.
294. 3H]norepinephrine release. J Pharmacol Exp Ther 1990;255:1060-1063.
295. Sacaan AI, Dunlop JL, Lloyd GK. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 1995;274:224-230.
296. Scanziani M, Gahwiler BH, Thompson SM. Presynaptic inhibition of excitatory synaptic transmission mediated by alpha adrenergic receptors in area CA3 of the rat hippocampus in vitro. J Neurosci 1993;13:5393-5401.
297. Scanziani M, Salin PA, Vogt KE, Malenka RC, Nicoll RA. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature 1997;385:630-634.
298. A receptor subtypes in adult rat hippocampus and cerebellum. Neuroscience 1996;73:697-704.
299. 2+ and MK-801. Eur J Pharmacol 1988;156:111-120.
300. 3H]norepinephrine from rat hippocampal slices. J Neurochem 1990;54:2077-2081.
301. Schneider JS, Rothblat DS, DiStefano L. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res 1994;643:86-91.
302. Schuman EM, Madison DV. Nitric oxide and synaptic function. Annu Rev Neurosci 1994;17:153-183.
303. Schwarcz R, Brush GS, Foster AC, French ED. Seizure activity and lesions after intrahippocampal quinolinic acid injection. Exp Neurol 1984;84:1-17.
304. Sershen H, Toth E, Lajtha A, Vizi ES. Nicotine effects on presynaptic receptor interactions. Ann N Y Acad Sci 1995;757:238-244.
305. Sershen H, Balla A, Lajtha A, Vizi ES. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 1997;77:121-130.
306. Shigemoto R, Kulik A, Roberts JD, Ohishi H, Nusser Z, Kaneko T, Somogyi P. Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature 1996;381: 523-525.
307. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 1997;17:7503-7522.
308. Shupliakov O, Brodin L, Cullheim S, Ottersen OP, Storm-Mathisen J. Immunogold quantification of glutamate in two types of excitatory synapse with different firing patterns. J Neurosci 1992;12:3789-3803.
309. Siddiqui F, Iqbal Z. Regulation of N-methyl-D-aspartate receptor-mediated calcium transport and norepinephrine release in rat hippocampus synaptosomes by polyamines. Neurochem Res 1994;19:1421-1429.
310. Singh A, Redfern P. Lack of circadian variation in the responsiveness of alpha 2-heteroreceptors regulating serotonin release. Chronobiol Int 1994;11:94-102.
311. 3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus. Synapse 1989;3:129-135.
312. 3H]norepinephrine release by phencyclidine is dependent on potassium concentration. Neurosci Lett 1987;78:333-337.
313. Snell LD, Yi SJ, Johnson KM. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMD A-induced norepinephrine release. Eur J Pharmacol 1988;145:223-226.
314. Somogyi P, Freund TF, Cowey A. The axo-axonic interneuron in the cerebral cortex of the rat, cat and monkey. Neuroscience 1982;7:2577-2607.
315. Speciale C, Facheris L, Fariello RG. Tetrodotoxin reveals action of spermine at presynaptic N-methyl-D-aspartate receptors. Eur J Pharmacol 1992;214:107-109.
316. 14C]glutamate from dentate gyrus is modulated by GABA. J Pharm Pharmacol 1986;38: 393-395.
317. Starke K. Influence of alpha-receptor stimulants on noradrenaline release. Naturwissenschaften 1971;58:420.
318. Starke K. Presynaptic receptors. Annu Rev Pharmacol Toxicol 1981;21: 7-30.
319. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 1989;69:864-989.
320. Stichel CC, Singer W. Organization and morphological characteristics of choline acetyltransferase-containing fibers in the visual thalamus and striate cortex of the cat. Neurosci Lett 1985;53:155-160.
321. Stillman MJ, Shukitt-Hale B, Kong RM, Levy A, Lieberman HR. Elevation of hippocampal extracellular acetylcholine levels by methoctramine. Brain Res Bull 1993;32:385-389.
322. 2 antagonists on in vivo hippocampal acetylcholine levels. Brain Res Bull 1996;41:221-226.
323. Strittmatter H, Jackisch R, Hertting G. Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1982;321:195-200.
324. Suzdak PD, Gianutsos G. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system. J Neural Transm 1985;62:77-89.
325. Suzuki M, Matsuda T, Asano S, Somboonthum P, Takuma K, Baba A. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1 A receptor activation. Br J Pharmacol 1995;115:703-711.
326. Szentágothai J. Synaptic structure and the concept of presynaptic inhibition. In: von Euler US, Skoglund D, Säderberg V, eds. Structure and function of inhibitory neuronal mechanisms. Oxford: Pergamon Press, 1968;15-31.
327. Szentágothai J, Arbib MA, Conceptual models of neural organization. Neurosci Res Prog Bull 1974;12:305-310.
328. Tanaka J, Ichikawa R, Watanabe M, Tanaka K, Inoue Y. Extra-junctional localization of glutamate transporter EAAT4 at excitatory Purkinje-cell synapses. Neuroreport 1997;8:2461-2464.
329. Tansey EM. Not committing barbarisms: Sherrington and the synapse, 1897. Brain Res Bull 1998;44:211-212.
330. Tao R, Auerbach SB. Differential effect of NMDA on extracellular serotonin in rat midbrain raphe and forebrain sites. J Neurochem 1996;66:1067-1075.
331. +-evoked release of endogenous glutamate from guinea pig hippocampal mossy fiber synaptosomes. Brain Res 1991;551:303-307.
332. Thomas DN, Holman RB. A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J Neurochem 1991;56:1741-1746.
333. Thompson SM, Capogna M, Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci 1993;16:222-227.
334. Toide K, Arima T. Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur J Pharmacol 1989;173:133-141.
335. Toth K, Borhegyi Z, Freund TF. Postsynaptic targets of GABAergic hippocampal neurons in the medial septum-diagonal band of broca complex. J Neurosci 1993;13:3712-3724.
336. Trendelenburg AU. The TiPS lecture: Functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol Sci 1991;12:334-337.
337. Trendelenburg AU, Limberger N, Starke K. Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1993;348:35-45.
338. Trendelenburg AU, Limberger N, Starke K. Subclassification of presynaptic alpha 2-adrenoceptors: alpha 2D-autoreceptors in guinea-pig atria and brain. Naunyn Schmiedebergs Arch Pharmacol 1995;352:49-57.
339. Ulus IH, Buyukuysal RL, Wurtman RJ. N-methyl-D-aspartate increases acetylcholine release from rat striatum and cortex: its effect is augmented by choline. J Pharmacol Exp Ther 1992;261:1122-1128.
340. Umbriaco D, Garcia S, Beaulieu C, Descarries L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus 1995;5:605-620.
341. 3H]-noradrenaline from rat spinal cord. Brain Res Bull 1997;42:129-132.
342. van Groen T, Wyss JM. Extrinsic projections from area CA1 of the rat hippocampus: olfactory, cortical, subcortical, and bilateral hippocampal formation projections. J Comp Neurol 1990;302:515-528.
343. Vannucchi MG, Pepeu G. Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci Lett 1995;190:53-56.
344. Vannucchi MG, Scali C, Kopf SR, Pepeu G, Casamenti F. S elective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience 1997;79:837-846.
345. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neuronal messenger. Science 1993;259:381-384.
346. 3H]norepinephrine release from hippocampal slices is an in vitro biochemical tool for investigating the pharmacological properties of excitatory amino acid receptors. J Neurochem 1987;49:1438-1442.
347. Vickroy TW, Malphurs WL, Defiebre NC. Absence of receptor reserve at hippocampal muscarinic autoreceptors which inhibit stimulus-dependent acetylcholine release. J Pharmacol Exp Ther 1993;267: 1198-1204.
348. Vignes M, Collingridge GL. The synaptic activation of kainate receptors. Nature 1997;388:179-182.
349. 4 receptors in the rat brain: evidence from combined in situ hybridization and receptor autoradiography. Synapse 1992;11:171-183.
350. Via ES. The inhibitory action of noradrenaline and adrenaline on release of acetylcholine from guinea-pig ileum longitudinal strips. Arch Exp Path Pharmacol 1968;259:199-200.
351. Via ES. Presynaptic modulation of neurochemical transmission. Prog Neurobiol 1979;12:181-290.
352. Via ES. Non-synaptic modulation of transmitter release: pharmacological implication. Trends Pharmacol Sci 1980;1:172-175.
353. Via ES. Non-synaptic interaction between neurons: modulation of neurochemical transmission. New York: Wiley, 1984.
354. Via ES. Non-synaptic inhibitory signal transmission between axon terminals: physiological and pharmacological evidence. In: Fuxe K, Agnati LF, eds. Volume transmission in the brain: novel mechanisms for neural transmission. New York: Raven Press, 1991:89-96.
355. Via ES. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem Int 1998;33:359-366.
356. Vizi ES, Knoll J. The effects of sympathetic nerve stimulation and guanethidine on parasympathetic neuroeffector transmission, the inhibition of acetylcholine release. J Pharm Pharmacol 1971;23:918-925.
357. Via ES, Lábos E. Non-synaptic interactions at presynaptic level. Prog Neurobiol 1991;37:145-163.
358. Vizi ES, Lendvai B. Side effects of non-depolarizing muscle relaxants: relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 1997;73:75-89.
359. Vizi ES, Somogyi GT, Hársing LG Jr, Zimanyi I. External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation. Proc Natl Acad Sci U S A 1985;82:8775-8780.
360. Vizi ES, Hársing LG Jr, Gaal J, Kapocsi J, Bernath S, Somogyi GT. CH-38083: a selective potent antagonist of alpha 2 adrenoceptors. J Pharmacol Exp Ther 1986;238:701-706.
361. Vizi ES, Kiss J, Elenkov IJ. Presynaptic modulation of cholinergic and noradrenergic neurotransmission : interaction between them. News Phys Sci 1991;6:119-123.
362. Via ES, Sershen H, Balla A, Mike A, Windisch K, Juranyi Z, Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann N Y Acad Sci 1995;757:84-99.
363. Via ES, Mike A, Tarnawa I. 2,3-benzodiazepines (GYKI 52466 and analogs): negative allosteric modulators of AMPA receptors. CNS Drug Rev 1996;2:91-126.
364. Vizi ES, Mike A, Tarnawa I. The functional study of kainate receptors-hopes and doubts. Trends Neurosci 1997;20:396-397.
365. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989;284:314-335.
366. Waldmeier PC, Wicki P, Feldtrauer JJ, Baumann PA. Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn Schmiedebergs Arch Pharmacol 1988;337:289-295.
367. Wang JK, Thukral V. Presynaptic NMDA receptors display physiological characteristics of homomeric complexes of NR1 subunits that contain the exon 5 insert in the N-terminal domain. J Neurochem 1996;66:865-868.
368. Wang JK, Andrews H, Thukral V. Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals. J Neurochem 1992;58:204-211.
369. Westerink BH, Damsma G, De Vries JB, Koning H. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur J Pharmacol 1987;135:123-128.
370. Whitton PS, Maione S, Biggs CS, Fowler LJ. Tonic desensitization of hippocampal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo. Neuroscience 1994a;63:945-948.
371. Whitton PS, Richards DA, Biggs CS, Fowler LJ. N-methyl-D-aspartate receptors modulate extracellular 5-hydroxytryptamine concentration in rat hippocampus and striatum in vivo. Neurosci Lett 1994b;169:215-218.
372. Wilkie GI, Hutson P, Sullivan JP, Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem Res 1996;21:1141-1148.
373. Winzer-Serhan UH, Raymon HK, Broide RS, Chen Y, Leslie FM. Expression of alpha 2 adrenoceptors during rat brain development - I. Alpha 2A messenger RNA expression. Neuroscience 1997;76:241-260.
374. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 1997;20:92-98.
375. 3H]norepinephrine release from rat hippocampal slices. J Pharmacol Exp Ther 1993;266:563-569.
376. Wu LG, Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 1997;20:204-212.
377. Yamamoto C, Sawada S, Takada S. Suppressing action of 2-amino-4-phosphonobutyric acid on mossy fiber-induced excitation in the guinea pig hippocampus. Exp Brain Res 1983;51:128-134.
378. Yoshino M, Kamiya H. Suppression of presynaptic calcium influx by metabotropic glutamate receptor agonists in neonatal rat hippocampus. Brain Res 1995;695:179-185.
379. Yoshioka M, Matsumoto M, Numazawa R, Togashi H, Smith CB, Saito H. Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment. Eur J Pharmacol 1995;294:565-570.
380. Young P, Berge J, Chapman H, Cawthorne MA. Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes. Eur J Pharmacol 1989;168:381-386.
381. Zhang WQ, Rogers BC, Tandon P, Hudson PM, Sobotka TJ, Hong JS, Tilson HA. Systemic administration of kainic acid increases GABA levels in perfusate from the hippocampus of rats in vivo. Neurotoxicology 1990;11:593-600.
382. Zhang X, Kindel GH, Wulfert E, Hanin I. Effects of immobilization stress on hippocampal monoamine release: modification by mivazerol, a new alpha 2-adrenoceptor agonist. Neuropharmacology 1995;34: 1661-1672.
383. Zhou M, Peterson CL, Lu YB, Nadler JV. Release of glutamate and aspartate from CA1 synaptosomes: selective modulation of aspartate release by ionotropic glutamate receptor ligands. J Neurochem 1995;64:1556-1566.
384. Zsilla G, Zelles T, Mike A, Kekes-Szabo A, Milusheva E, Vizi ES. Differential changes in presynaptic modulation of transmitter release during aging. Int J Dev Neurosci 1994;12:107-115.